Abstract
In this issue of Blood, Thompson et al present their exciting long-Term results with the use of fludarabine, cyclophosphamide, and rituximab (FCR) chemoimmunotherapy in patients with previously untreated chronic lymphocytic leukemia (CLL).1.
Cite
CITATION STYLE
APA
Awan, F. T. (2016). Cure for CLL? Blood, 127(3), 274. https://doi.org/10.1182/blood-2015-11-678532
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free